Melflufen Synthesis via Segmented Chlorination
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing processes for preparing Melflufen, a DNA alkylating drug used in treating multiple myeloma, face challenges such as the toxicity of starting materials like L-Melphalan and the inefficiencies of chlorination methods using SOCl2 or POCl3, which are not suitable for high-scale production.
Innovation Solution
A process involving the reaction of a compound of formula (2) with a compound of formula (3) to produce compound of formula (4), followed by conversion to Melflufen or its salt, using a nitrogen protective group and specific alkyl groups, which allows for high yield and purity and is suitable for high-scale production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If L-Melphalan is used as starting material, then Melflufen can be prepared, but the process is not suitable for high scale preparation due to high toxicity
Solution Approach 1:
The synthesis is divided into multiple steps with intermediate purification stages. The process segments the toxic L-Melphalan usage into controlled laboratory-scale steps rather than continuous large-scale operation, allowing toxicity management through isolated handling and disposal protocols at each stage.
2Manufacturing precision
If column chromatography is used for purification, then pure Melflufen can be obtained, but the process is not suitable for high scale preparation
Solution Approach 1:
Impurities are selectively extracted and removed at intermediate stages using extraction techniques rather than requiring final-stage column chromatography. This removes problematic byproducts early in the process, enabling scale-up without the bottleneck of large-column chromatography while maintaining product purity.
Solution Approach 2:
The process discards problematic impurities through selective removal steps and recovers the main product through crystallization. By discarding impurities early rather than requiring complete purification at the end, the process becomes scalable while maintaining manufacturing precision.
3Productivity
If SOCl2 or POCl3 is used for chlorination, then Melflufen can be prepared, but the process requires long temperatures and high reaction times or produces significant de-protected side product
Solution Approach 1:
The chlorination step uses modified reaction parameters including controlled temperature ranges and optimized reagent ratios. These parameter changes enable the reaction to proceed efficiently with high selectivity, avoiding both the high temperature/long time requirements and the side product formation associated with conventional conditions.
Solution Approach 2:
The process employs a composite approach combining specific chlorinating reagents with catalysts or additives that enhance selectivity. This composite reaction system achieves high productivity while maintaining manufacturing precision by suppressing de-protected side products through synergistic chemical interactions.
Data Source
Figure 1
AI summary
The present invention relates to process for preparing Melflufen, compound of formula (1) or a salt thereof, and to intermediates used in the process and solid forms thereof.